Breakthrough procedure helps prevent amputations for Sacramento area patients
(FOX40.COM) — A breakthrough surgery helping save limbs and lives took place in Sacramento on Wednesday morning.
The procedure aims to treat people suffering from Peripheral Artery Disease. PAD is a serious and rarely-treated circulatory condition that restricts blood flow to the limbs due to narrowed blood vessels. It kills more people than breast, colon, and prostate cancer combined.
'Plaque that builds up in these arteries causes not only hardening of the arteries but also plaque in these blood vessels,' said Dr. Inder Singh, an interventional cardiovascular specialist at TLC Vascular.
When blood can't flow properly, minor wounds can become dangerous. They can lead to infection and, in some cases, amputation.
Michaels Distributing Center in San Joaquin County set to close, affecting over 200 jobs
'If they get an injury or they get a wound or they get a scratch, those will not heal because they don't have enough, adequate perfusion to heal those wounds,' Dr. Singh said.
Helping to change patient outcomes, Dr. Singh is now performing a first-of-its-kind procedure using a newly FDA-cleared removable stent called SPUR.
'The idea with it is that basically that kind of treatment that deep penetrates into the tissue and treats it, it will prevent future closure or at least prolong the time from when the blood vessels close,' said Dr. Singh. 'Enabling the patients to be able to heal their wounds, which is really the main outcome we're looking for.'
Dr.Singh is the first in the Sacramento area to use SPUR, designed specifically for the small, fragile arteries below the knee. Unlike a traditional stent, the spur temporarily holds the vessel open and then is removed, leaving nothing behind.
Charges filed against former Cal Fire employee in child pornography case
'We can see somebody on an outpatient basis one day and actually fix a problem rather than put a band-aid on, you know, the incorrect problem,' said Shelby Adney, a nurse practitioner at TLC Vascular.
It's an innovative procedure now preventing amputations, healing wounds, and maintaining patients' normal lives.
'Once you can preserve that and heal their wounds… they get their life back,' Dr. Singh said. 'They're ambulatory. They can spend time with their family. You can do a lot of things that most people expect to do.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Kentucky health officials warn against use of kratom
LEXINGTON, Ky. (FOX 56) — Kratom is a tropical tree found in Southeast Asia, and it has been around for hundreds of years. Its leaves are sold throughout the United States and can treat things like pain, coughing, anxiety, depression, and even opioid use disorder and withdrawal. 'It is sold in Kentucky. Usually, it will come in either an herbal powder form or in a pill form,' said Program Director for Voices of Hope Lexington, Jimmy Chadwell. Kentucky health officials warn against use of kratom Kentucky judge tells lawmakers child removal process doesn't move quick enough in abuse investigations 1 charged, shelter-in-place ended in Saunders Lane after Boone County shooting investigation In early June, the Kentucky Department for Public Health and the Kentucky Office of Drug Control Policy put out a health alert advising the public not to consume kratom products and products containing 7-hydroxymitragynine, better known as 7-OH. It is a chemical compound found in kratom. The health agencies warned that when 7-OH is concentrated or synthetically made, it can increase the risk of overdose, severe health issues, and death. Chadwell urges those using pure kratom products for their harm-reduction benefits to do so wisely. Kentuckians spend the 3rd highest share of their income on fast food Bill could make federal minimum wage $15: Kentucky among states paying less than that Kentucky sitting near bottom of rankings in environmental protection: Study 'Exercise caution. Moderate the amount you use. Never use it alone. Always have Narcan available. Okay? Because of these kratom and the 7-OH, they work on the opioid receptors. So having Narcan available is really going to save somebody's life,' he told FOX 56. Kratom is not FDA-approved and is illegal in six states. But Chadwell said that Voices of Hope, an organization for people recovering from substance abuse disorders, believes the answer is not more laws; it is more conversation. 'We believe that creating more laws surrounding drugs and drug users will not help the community. Instead, we feel that supporting increases in the availability of education and encouraging harm reduction initiatives when using any substance are the best route to go,' he said. Read more of the latest health and wellness news Health officials also said there are no guarantees that kratom products contain the ingredients the packages claim, have the correct concentrations, or are free from contaminants or other drugs. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 hours ago
- Yahoo
Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer's Disease
TAINAN, June 12, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer's disease (AD). TML-6 combines multiple mechanisms, including anti-oxidative effects (Nrf2 activation), melioration of autophagy function (autolysosomal activation), anti-amyloid accumulation (β-amyloid clearance), and anti-inflammatory effects (through NF-κB inhibition) through autolysosome pathway in neurons and microglia to remove intraneuronal and extracellular amyloid accumulation, representing the first in human multi-target strategy for AD treatment. The Phase I trial showed excellent safety, tolerability, and pharmacokinetics at 100–200 mg in both healthy and elderly adults. TML-6 will now advance to a Phase II 19 site trial across the United States, Sweden, and Taiwan after FDA approval. This 12-month study will enroll 210 patients with mild cognitive impairment (MCI) or mild dementia. Primary endpoints will include neuropsychological assessments (CDR-SB, iADRS) and blood biomarkers (p-Tau 217, Aβ42/40, NfL, GFAP), supported by brain MRI, amyloid PET scans, and ApoE genotyping. Type C FDA consultation for phase 2 trial design has completed on 13 May 2025, with trial initiation expected in April 2026, conducted by Syneos Health CRO. With its strong preclinical and clinical profile, TML-6 holds promise as both a monotherapy and in combination with anti-amyloid biologics, providing new hope for patients with Alzheimer's disease. About Merry Life Biomedical Company Merry Life Biomedical is a Taiwan-based biotechnology company focused on developing innovative therapies for neurodegenerative and age-related diseases. Leveraging advanced molecular design, pharmacological innovation, formulation optimization and global clinical development, the company is committed to addressing urgent unmet medical needs. Media ContactDr. Ih-Jen SuMerry Life Biomedical Company, +886-910-902-296Email: suihjen0704@ View original content to download multimedia: SOURCE Merry Life Biomedical Company, Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Meet the tree that could save Florida's citrus industry
Matt Mattia used both hands to flip through the branch at his eye level, studying each side of every leaf as sunlight filtered from above. 'Just healthy leaves,' he said, noting the dark green color. He turned his attention to a young fruit that was still the same color as the leaf next to it. 'That looks pretty symmetrical,' he said, plucking it for further examination. 'That should develop into a nice, big orange.' Mattia is no farmer, and the tree was no ordinary plant. He works for the United States Department of Agriculture as a geneticist. The tree has a name: Donaldson. Mattia called it the most researched tree in the state of Florida. It's also the tree that growers hope will save the state's citrus industry. 'When I saw the Donaldson tree, I was like, 'Wow, this is something that's really unique and really different,'' Mattia said. Donaldson's notoriety has come from its unique combination of three attributes: its status as a genetically pure orange tree, its sweet taste, and most importantly, its resistance to the Huanglongbing disease, more commonly known as HLB or 'greening.' Since arriving in the United States from Brazil, greening has killed groves across the state of Florida and contributed to a 90% decline in citrus production over the past 20 years. Leaves of infected trees appear splotchy in color and can be abnormally shaped. The tree's fruit also takes on irregular characteristics – until the tree dies. While it has infected almost every variety of citrus tree, it hit one of two types of orange trees particularly hard: the Hamlin variety, which fruits early in the winter before the late-season Valencia oranges came in. Under FDA rules, Hamlins and Valencias are the two major types of oranges that are allowed to be used for Florida orange juice, Mattia explained. Without the Hamlin trees, growers' profits suffered. Donaldson is also an early season tree. It was planted 30 years ago when the USDA created its Groveland research farm with different citrus varieties that growers could fall back on, like a seed bank. Mattia found it by sampling 25,000 different trees to test for infection and fruit sweetness. He found other trees tolerated greening, but their fruit was bitter, bordering on inedible, he recalled. Donaldson, with its high sugar content, stood out. A Hamlin tree was planted near Donaldson at the same time. Mattia pointed at the spot, which was nothing more than the remnant of a trunk sticking out of the ground and a pink ribbon tied around it. Greening did most of the damage, and Hurricane Milton finished it off, he said. 'It just was a huge stark contrast between something that was really very, very sick and declining and something that appears to continue to produce a regular crop,' he explained. 'We took the fruit, we sampled the fruit, and we tasted it, and we were like, wow, this has industry potential.' Now that they've settled on a tree, Mattia and his team have been figuring out what it would take to make Donaldson a commercial success. Several researchers analyzed the taste, which to the average palette is identical to Hamlin and Valencia. The best method to produce orange juice was also looked at, with Mattia opening a bottle that had been created using a method new to their research. Mattia's team is now working on the next phase of their testing: monitoring young Donaldsons that had been grafted onto dozens of different rootstocks to see which combination of plants grow the strongest and fastest. One Hamlin tree planted among the Donaldsons as a control showed signs of greening infection. Mattia said it was highly likely many of the healthy-looking nine-month-old plants had already been hit, though as a researcher it only helped him get further to his goal. But the USDA isn't gate-keeping Donaldson, even though the tree itself is grown behind fences and locks. 'We're pushing it out to commercial usage,' Mattia said. 'If people want to test it in their own grove, it's available, and we have the data and the research going on here that supports that effort.' Florida is already on-board. Mattia said the state has propagated 18,000 Donaldsons that it's sending to growers across the state to accelerate the adoption effort. One of those potentially interested is Mary Graham, owner of Graham's U-Pick Farms, who had heard of Donaldson and wanted to know how many seeds each fruit had (five to seven) and whether the fruit was edible when freshly picked (yes). For a century, Graham's specialized in oranges. As of this year, they only grow peaches. 'We noticed greening hitting our grove probably about 15 years ago,' she recalled. 'About 10, 12, years ago, it started getting a little more aggressive. So at that point, we looked for an alternative crop.' Like her neighbors, Graham tried different methods to save her trees. She and her husband added more nutrients to the soil and cut down on chemicals, which she said helped the trees recover. Eventually, the disease won the battle, and her husband tore out the last of the trees in January. She's looking to plant new seedlings for her children to eventually care for, even though she said her peaches were better for business. 'We're hopeful about the Donaldson tree,' she said. 'With that one, what else can they come up with?' That's what Mattia is all about. He previewed 'future orange juice,' a blend of different citrus fruits that resembles orange juice but has a notable flavor difference that's being created as an alternative to Donaldson in case the tree doesn't work out. 'My mission is to really help people,' he said. 'So if they, if the industry and the processors find utility from this tree, I feel like our mission is accomplished.' Click here to download our free news, weather and smart TV apps. And click here to stream Channel 9 Eyewitness News live.
